| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 316.72B | 317.12B | 348.28B | 342.25B | 289.34B | 217.12B |
| Gross Profit | 39.23B | 39.18B | 32.38B | 33.34B | 34.41B | 33.84B |
| EBITDA | 7.36B | 6.89B | 3.17B | 4.95B | 8.47B | 6.15B |
| Net Income | 3.32B | 3.15B | -1.04B | 478.00M | 2.49B | 2.72B |
Balance Sheet | ||||||
| Total Assets | 88.45B | 105.93B | 108.48B | 101.35B | 104.91B | 96.83B |
| Cash, Cash Equivalents and Short-Term Investments | 12.14B | 11.92B | 12.04B | 10.23B | 10.24B | 10.08B |
| Total Debt | 3.95B | 5.48B | 12.27B | 6.94B | 5.53B | 7.74B |
| Total Liabilities | 33.72B | 50.70B | 55.16B | 47.72B | 50.52B | 44.92B |
| Stockholders Equity | 54.70B | 55.21B | 53.30B | 53.62B | 53.69B | 51.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.26B | -3.38B | -3.71B | -844.00M | 5.28B |
| Operating Cash Flow | 0.00 | 10.53B | -945.00M | 389.00M | 1.13B | 7.95B |
| Investing Cash Flow | 0.00 | -2.76B | -1.67B | -698.00M | 2.15B | 36.00M |
| Financing Cash Flow | 0.00 | -7.59B | 4.28B | 435.00M | -3.12B | -5.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥127.24B | 17.49 | ― | 2.57% | 7.46% | 153.98% | |
73 Outperform | ¥22.93B | 20.21 | ― | 4.50% | 13.76% | 13.58% | |
68 Neutral | ¥1.81T | 21.95 | 2.23% | 3.07% | -7.68% | -73.03% | |
67 Neutral | ¥74.24B | 32.15 | ― | 1.37% | -5.02% | 186.97% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | ¥218.65B | 12.70 | ― | 3.45% | -4.87% | 26.27% | |
56 Neutral | ¥3.63T | 11.54 | -0.15% | 2.74% | -14.13% | 33.18% |